vs
QCR HOLDINGS INC（QCRH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是QCR HOLDINGS INC的1.8倍（$197.9M vs $107.0M），QCR HOLDINGS INC同比增速更快（16.5% vs 13.6%），QCR HOLDINGS INC自由现金流更多（$354.1M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -13.2%）
QCR控股有限公司通过旗下子公司，为阔德城和锡达拉皮兹地区的客户提供商业与零售银行服务，以及信托和资产管理服务。公司成立于1993年，总部位于伊利诺伊州莫林市。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
QCRH vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$107.0M
营收增速更快
QCRH
高出2.9%
13.6%
自由现金流更多
QCRH
多$336.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
-13.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.0M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 36.1% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 16.5% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $2.10 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QCRHRGEN
| Q4 25 | $107.0M | $197.9M | ||
| Q3 25 | $101.5M | $188.8M | ||
| Q2 25 | $84.2M | $182.4M | ||
| Q1 25 | $76.9M | $169.2M | ||
| Q4 24 | $91.8M | $174.1M | ||
| Q3 24 | $152.6M | $154.9M | ||
| Q2 24 | $150.6M | $154.1M | ||
| Q1 24 | $141.9M | $151.3M |
净利润QCRHRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $36.7M | $14.9M | ||
| Q2 25 | $29.0M | $14.9M | ||
| Q1 25 | $25.8M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $27.8M | $-654.0K | ||
| Q2 24 | $29.1M | $3.3M | ||
| Q1 24 | $26.7M | $2.1M |
毛利率QCRHRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率QCRHRGEN
| Q4 25 | 36.1% | 9.0% | ||
| Q3 25 | 40.0% | 8.9% | ||
| Q2 25 | 36.3% | 7.6% | ||
| Q1 25 | 34.0% | 3.9% | ||
| Q4 24 | 36.1% | -17.7% | ||
| Q3 24 | 19.6% | -5.1% | ||
| Q2 24 | 21.0% | 1.0% | ||
| Q1 24 | 19.7% | 1.3% |
净利率QCRHRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 36.2% | 7.9% | ||
| Q2 25 | 34.5% | 8.2% | ||
| Q1 25 | 33.6% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 18.2% | -0.4% | ||
| Q2 24 | 19.3% | 2.2% | ||
| Q1 24 | 18.8% | 1.4% |
每股收益（稀释后）QCRHRGEN
| Q4 25 | $2.10 | $0.24 | ||
| Q3 25 | $2.16 | $0.26 | ||
| Q2 25 | $1.71 | $0.26 | ||
| Q1 25 | $1.52 | $0.10 | ||
| Q4 24 | $1.77 | $-0.55 | ||
| Q3 24 | $1.64 | $-0.01 | ||
| Q2 24 | $1.72 | $0.06 | ||
| Q1 24 | $1.58 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $9.6B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资QCRHRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务QCRHRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益QCRHRGEN
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $997.4M | $2.0B | ||
| Q3 24 | $976.6M | $2.0B | ||
| Q2 24 | $936.3M | $2.0B | ||
| Q1 24 | $907.3M | $2.0B |
总资产QCRHRGEN
| Q4 25 | $9.6B | $2.9B | ||
| Q3 25 | $9.6B | $2.9B | ||
| Q2 25 | $9.2B | $2.9B | ||
| Q1 25 | $9.2B | $2.9B | ||
| Q4 24 | $9.0B | $2.8B | ||
| Q3 24 | $9.1B | $2.8B | ||
| Q2 24 | $8.9B | $2.9B | ||
| Q1 24 | $8.6B | $2.8B |
负债/权益比QCRHRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $421.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $354.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 330.9% | 8.9% |
| 资本支出强度资本支出/营收 | 63.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $397.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流QCRHRGEN
| Q4 25 | $421.5M | $25.7M | ||
| Q3 25 | $47.5M | $48.1M | ||
| Q2 25 | $42.2M | $28.6M | ||
| Q1 25 | $-3.6M | $15.0M | ||
| Q4 24 | $444.5M | $39.2M | ||
| Q3 24 | $238.1M | $49.3M | ||
| Q2 24 | $26.3M | $42.2M | ||
| Q1 24 | $2.7M | $44.7M |
自由现金流QCRHRGEN
| Q4 25 | $354.1M | $17.6M | ||
| Q3 25 | $31.7M | $43.4M | ||
| Q2 25 | $24.2M | $21.5M | ||
| Q1 25 | $-12.7M | $11.4M | ||
| Q4 24 | $400.0M | $33.6M | ||
| Q3 24 | $229.9M | $42.3M | ||
| Q2 24 | $16.2M | $37.4M | ||
| Q1 24 | $-9.4M | $36.4M |
自由现金流率QCRHRGEN
| Q4 25 | 330.9% | 8.9% | ||
| Q3 25 | 31.3% | 23.0% | ||
| Q2 25 | 28.8% | 11.8% | ||
| Q1 25 | -16.5% | 6.8% | ||
| Q4 24 | 435.6% | 19.3% | ||
| Q3 24 | 150.7% | 27.3% | ||
| Q2 24 | 10.7% | 24.3% | ||
| Q1 24 | -6.6% | 24.0% |
资本支出强度QCRHRGEN
| Q4 25 | 63.0% | 4.1% | ||
| Q3 25 | 15.5% | 2.5% | ||
| Q2 25 | 21.4% | 3.9% | ||
| Q1 25 | 11.9% | 2.1% | ||
| Q4 24 | 48.4% | 3.2% | ||
| Q3 24 | 5.4% | 4.5% | ||
| Q2 24 | 6.8% | 3.1% | ||
| Q1 24 | 8.6% | 5.5% |
现金转化率QCRHRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.29× | 3.23× | ||
| Q2 25 | 1.46× | 1.92× | ||
| Q1 25 | -0.14× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.57× | — | ||
| Q2 24 | 0.90× | 12.70× | ||
| Q1 24 | 0.10× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
